Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis

References

1. 1.↵
   2. Hoshide R,
   3. Jandial R

   . 2016 World Health Organization Classification of Central Nervous System Tumors: an era of molecular biology. World Neurosurg 2016;94:561–62 doi:10.1016/j.wneu.2016.07.082 pmid:27476688

   CrossRefPubMed
2. 2.↵
   2. Solomon DA,
   3. Wood MD,
   4. Tihan T, et al

   . Diffuse midline gliomas with H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 2016;26:569–80 doi:10.1111/bpa.12336 pmid:26517431

   CrossRefPubMed
3. 3.↵
   2. Castel D,
   3. Philippe C,
   4. Calmon R, et al

   . Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 2015;130:815–27 doi:10.1007/s00401-015-1478-0 pmid:26399631

   CrossRefPubMed
4. 4.↵
   2. Korshunov A,
   3. Ryzhova M,
   4. Hovestadt V, et al

   . Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol 2015;129:669–78 doi:10.1007/s00401-015-1405-4 pmid:25752754

   CrossRefPubMed
5. 5.↵
   2. Aboian MS,
   3. Solomon DA,
   4. Felton E, et al

   . Imaging characteristics of pediatric diffuse midline gliomas with histone mutation. AJNR Am J Neuroradiol 2017;38:795–800 doi:10.3174/ajnr.A5076 pmid:28183840

   Abstract/FREE Full Text
6. 6.↵
   2. Rodriguez Gutierrez D,
   3. Awwad A,
   4. Meijer L, et al

   . Metrics and textural features of MRI diffusion to improve classification of pediatric posterior fossa tumors. AJNR Am J Neuroradiol 2014;35:1009–15 doi:10.3174/ajnr.A3784 pmid:24309122

   Abstract/FREE Full Text
7. 7.↵
   2. Bull JG,
   3. Saunders DE,
   4. Clark CA, et al

   . Discrimination of paediatric brain tumours using apparent diffusion coefficient histograms. Eur Radiol 2012;22:447–57 doi:10.1007/s00330-011-2255-7 pmid:21918916

   CrossRefPubMed
8. 8.↵
   2. Nowosielski M,
   3. Recheis W,
   4. Goebel G, et al

   . ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma. Neuroradiology 2011;53:291–302 doi:10.1007/s00234-010-0808-0 pmid:21125399

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Pope WB,
   3. Lai A,
   4. Mehta R, et al

   . Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol 2011;32:882–89 doi:10.3174/ajnr.A2385 pmid:21330401

   Abstract/FREE Full Text
10. 10.↵
    2. Pope WB,
    3. Kim HJ,
    4. Huo J, et al

    . Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology 2009;252:182–89 doi:10.1148/radiol.2521081534 pmid:19561256

    CrossRefPubMedWeb of Science
11. 11.↵
    2. Sturm D,
    3. Witt H,
    4. Hovestadt V, et al

    . Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012;22:425–37 doi:10.1016/j.ccr.2012.08.024 pmid:23079654

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Poussaint TY,
    3. Vajapeyam S,
    4. Ricci KI, et al

    . Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium. Neuro Oncol 2016;18:725–34 doi:10.1093/neuonc/nov256 pmid:26487690

    CrossRefPubMed
13. 13.↵
    2. Nikbakht H,
    3. Panditharatna E,
    4. Mikael LG, et al

    . Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat Commun 2016;7:11185 doi:10.1038/ncomms11185 pmid:27048880

    CrossRefPubMed